Corient Private Wealth’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Buy |
101,138
+43,707
| +76% | +$9.56M | 0.02% | 418 |
|
|
2025
Q1 | $12.9M | Sell |
57,431
-46,650
| -45% | -$10.4M | 0.02% | 464 |
|
|
2024
Q4 | $34.1M | Sell |
104,081
-2,746
| -3% | -$899K | 0.06% | 286 |
|
|
2024
Q3 | $32.1M | Buy |
106,827
+29,222
| +38% | +$8.77M | 0.05% | 314 |
|
|
2024
Q2 | $25.6M | Buy |
77,605
+13,062
| +20% | +$4.3M | 0.04% | 342 |
|
|
2024
Q1 | $25.5M | Buy |
64,543
+1,284
| +2% | +$508K | 0.05% | 342 |
|
|
2023
Q4 | $22.3M | Sell |
63,259
-210
| -0.3% | -$73.9K | 0.04% | 368 |
|
|
2023
Q3 | $23.8M | Buy |
63,469
+919
| +1% | +$345K | 0.05% | 309 |
|
|
2023
Q2 | $23.9M | Sell |
62,550
-497
| -0.8% | -$190K | 0.06% | 306 |
|
|
2023
Q1 | $21.8M | Buy |
63,047
+60,127
| +2,059% | +$20.8M | 0.06% | 285 |
|
|
2022
Q4 | $686K | Buy |
+2,920
| New | +$686K | ﹤0.01% | 1038 |
|